

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | COX ↓ ↑ | COX-1 ↓ ↑ | COX-2 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piroxicam | ✔ | 98% | |||||||||||||||||
| Salicylic acid | ✔ | 98% | |||||||||||||||||
| Phenacetin | ✔ | 98% | |||||||||||||||||
| Etodolac | ✔ | 99% | |||||||||||||||||
| Flunixin meglumine | ✔ | 98% | |||||||||||||||||
| Ibuprofen L-lysine | ✔ | 98% | |||||||||||||||||
| Nabumetone | ✔ | 98% | |||||||||||||||||
| Acemetacin | ✔ | 98% | |||||||||||||||||
| Diflunisal | ✔ | 98% | |||||||||||||||||
| Pranoprofen | ✔ | 98% | |||||||||||||||||
| Ampiroxicam | ✔ | 98% | |||||||||||||||||
| Meloxicam | ✔ | 98% | |||||||||||||||||
| Sulindac | ✔ | 98% | |||||||||||||||||
| Ketoprofen | ✔ | 98% | |||||||||||||||||
| Mefenamic Acid | ✔ | 95% | |||||||||||||||||
| Bromfenac sodium | ✔ | 98% | |||||||||||||||||
| Oxaprozin | ✔ | 99% | |||||||||||||||||
| Aspirin | ✔ | 99% | |||||||||||||||||
| Nepafenac | ✔ | 98% | |||||||||||||||||
| Zaltoprofen | ✔ | 99% | |||||||||||||||||
| Salicin | ✔ | 98% | |||||||||||||||||
| Suprofen | ✔ | 99%+ | |||||||||||||||||
| Xanthohumol | ✔ | 99% | |||||||||||||||||
| Parecoxib | ✔ | 98% | |||||||||||||||||
| Tolfenamic Acid |
+++
COX-2, IC50: 0.2 μM |
98% | |||||||||||||||||
| Etoricoxib | ✔ | 99% | |||||||||||||||||
| Niflumic Acid | ✔ | 98% | |||||||||||||||||
| Valdecoxib |
++++
COX-2, IC50: 5 nM |
99+% | |||||||||||||||||
| Ibuprofen |
+
COX-1, IC50: 13 μM |
+
COX-2, IC50: 370 μM |
98% | ||||||||||||||||
| Indomethacin |
++
COX1, IC50: 0.28 μM |
+
COX-2, IC50: 14 μM |
97% | ||||||||||||||||
| Lornoxicam |
++++
COX-1, IC50: 5 nM |
++++
COX-2, IC50: 8 nM |
98% | ||||||||||||||||
| Meclofenamic acid sodium |
++++
COX-1, IC50: 40 nM |
+++
COX-2, IC50: 50 nM |
99% | ||||||||||||||||
| Asaraldehyde | ✔ | 98% | |||||||||||||||||
| Naproxen |
+
COX-1, IC50: 8.7 μM |
+
COX-2, IC50: 5.2 μM |
98% | ||||||||||||||||
| Diclofenac Sodium Salt |
+++
COX-1, IC50: 60 nM |
+++
COX-2, IC50: 200 nM |
98% | ||||||||||||||||
| NS-398 |
++
COX-2, IC50: 3.8 μM |
95% | |||||||||||||||||
| Amfenac Sodium Hydrate |
++
COX-1, IC50: 250 nM |
+++
COX-2, IC50: 150 nM |
98%+ | ||||||||||||||||
| Nimesulide |
+
COX-2, IC50: 26 μM |
98% | |||||||||||||||||
| Lumiracoxib |
++
COX-1, Ki: 3 μM |
+++
COX-2, Ki: 60 nM |
98% | ||||||||||||||||
| Rutaecarpine | ✔ | 95% | |||||||||||||||||
| Celecoxib |
++++
COX-2, IC50: 40 nM |
98% | |||||||||||||||||
| Carprofen |
++++
canine COX2, IC50: 30 nM |
98% | |||||||||||||||||
| Ketorolac |
++
COX-1 (human), IC50: 1.23 μM |
++
COX-2 (human), IC50: 3.50 μM |
98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 |
|
| 描述 | Xanthohumol is one of the principal flavonoids isolated from hops, the inhibitor of diacylglycerol acetyltransferase (DGAT), COX-1 and COX-2, and shows anti-cancer and anti-angiogenic activities. Xanthohumol significantly attenuates ADP-induced blood platelet aggregation, and significantly reduces the expression of fibrinogen receptor (activated form of GPIIbIIIa) on platelets' surface[3]. 5-50 nM xanthohumol reduced the frequency of spontaneously occurring Ca2+ sparks (>threefold) and Ca2+ waves in control myocytes and in cells subjected to Ca2+ overload caused by the following: 1) exposure to low K+ solutions, 2) periods of high frequency electrical stimulation, 3) exposures to isoproterenol, or 4) caffeine. At room temperatures, 50-100 nM xanthohumol reduced the rate of relaxation of electrically- or caffeine-triggered Ca2+transients, without suppressing ICa, but this effect was small and reversed by isoproterenol at physiologic temperatures. Xanthohumol also suppressed the Ca2+ content of the SR and its rate of recirculation[4]. The anti-angiogenic activity of XN was more potent than epigallocatechin-3-gallate (EGCG). Treatment of endothelial cells with XN led to increased AMPK (5' adenosine monophosphate-activated protein kinase) phosphorylation and activity[5]. XN significantly reduced cell viability and induced apoptosis via pro-caspase-3/8 cleavage and poly(ADP ribose) polymerase (PARP) degradation[6]. In addition, a xanthohumol-enriched hop extract displayed a weak to moderate antiviral activity against BVDV (bovine viral diarrhea virus) (therapeutic index (TI)=6.0), HSV-2 (TI=>5.3), Rhino (TI=4.0) and HSV-1 (TI=>1.9) with IC(50) values in the low microg/ml range. Xanthohumol accounted for the antiviral activity observed in the xanthohumol-enriched hop extract against BVDV, HSV-1 (herpes simplex virus type 1) and HSV-2. Xanthohumol also showed antiviral activity against CMV (cytomegalovirus), suggesting that it might have a generalized anti-herpesvirus antiviral activity. Again, superior antiviral activity was observed with the xanthohumol isomer against CMV[7]. |
| Concentration | Treated Time | Description | References | |
| RAW 264.7 cells | 0, 0.625, 1.25, 2.5, 5, 10 or 20 µM | 1 hour | To evaluate the effects of Xn and LPS on cell viability, the results showed that LPS (1 μg/mL) plus Xn up to 10 μM were not toxic to RAW 264.7 cells. | Redox Biol. 2017 Aug;12:311-324. |
| RAW 264.7 cells | 1.25, 2.5 or 5 µM | 1 hour | To evaluate the effects of Xn on LPS-induced inflammatory responses, the results showed that Xn significantly inhibited LPS-induced TNF-α, IL-6, IL-1β and ROS production. | Redox Biol. 2017 Aug;12:311-324. |
| HCC827OR | 0 µM, 1.5 µM, 3 µM, 6 µM | 24 hours | Xanthohumol significantly inhibited the proliferation and colony formation ability of HCC827OR and H1975OR cells and induced intrinsic apoptosis. | Cell Death Discov. 2024 Oct 28;10(1):454. |
| H1975OR | 0 µM, 1.5 µM, 3 µM, 6 µM | 24 hours | Xanthohumol significantly inhibited the proliferation and colony formation ability of HCC827OR and H1975OR cells and induced intrinsic apoptosis. | Cell Death Discov. 2024 Oct 28;10(1):454. |
| A549 cells | 2.5-10 µM | 24 hours | XN at non-cytotoxic concentrations significantly inhibited the migration and invasion capacity of A549 cells by reducing the expression of MMP-9 and increasing the expression of TIMP-1, thereby impairing PMA-induced invasive behavior. | Cells. 2021 Jun 12;10(6):1484. |
| HCT116 cells | 5 µM | 24 hours | Xanthohumol significantly inhibited glucose consumption and lactate production in HCT116 cells, and inhibited cell proliferation and colony formation | Int J Biol Sci. 2019 Sep 7;15(11):2497-2508. |
| SW620 cells | 5 µM | 24 hours | Xanthohumol significantly inhibited glucose consumption and lactate production in SW620 cells, and inhibited cell proliferation and colony formation | Int J Biol Sci. 2019 Sep 7;15(11):2497-2508. |
| HT29 cells | 5 µM | 24 hours | Xanthohumol significantly inhibited glucose consumption and lactate production in HT29 cells, and inhibited cell proliferation and colony formation | Int J Biol Sci. 2019 Sep 7;15(11):2497-2508. |
| Vero-E6 cells | 5.93 µM (IC50) | 24 hours | Xanthohumol inhibited SARS-CoV-2 replication with an IC50 value of 5.93 µM and did not significantly affect cell growth at high concentrations. | Int J Mol Sci. 2021 Nov 9;22(22):12134. |
| Vero-E6 cells | 7.51 µM (IC50) | 24 hours | Xanthohumol inhibited PEDV replication with an IC50 value of 7.51 µM. | Int J Mol Sci. 2021 Nov 9;22(22):12134. |
| Rat glioma C6 cell | 5 µM to 60 µM | 24 hours to 96 hours | XN significantly inhibited the proliferation of C6 glioma cells and eventually induced cell death by triggering mitochondrial stress. | Int J Mol Sci. 2021 Apr 26;22(9):4506. |
| CLB70 (B-cell leukemia) | 0.1–30 µM | 48 hours | All eight of the tested flavonoids exerted concentration-dependent cytotoxicity in the selected canine lymphoma/leukemia cell lines. Three compounds markedly decreased the viability of all cell lines with IC50 in the range of 0.5 to 8 µM. | Int J Mol Sci. 2023 Jul 21;24(14):11724. |
| CLBL-1 (B-cell lymphoma) | 0.1–30 µM | 48 hours | All eight of the tested flavonoids exerted concentration-dependent cytotoxicity in the selected canine lymphoma/leukemia cell lines. Three compounds markedly decreased the viability of all cell lines with IC50 in the range of 0.5 to 8 µM. | Int J Mol Sci. 2023 Jul 21;24(14):11724. |
| GL-1 (B-cell leukemia) | 0.1–30 µM | 48 hours | All eight of the tested flavonoids exerted concentration-dependent cytotoxicity in the selected canine lymphoma/leukemia cell lines. Three compounds markedly decreased the viability of all cell lines with IC50 in the range of 0.5 to 8 µM. | Int J Mol Sci. 2023 Jul 21;24(14):11724. |
| Administration | Dosage | Frequency | Description | References | ||
| Nude mice | Colorectal cancer xenograft model | Intraperitoneal injection | 10 mg/kg | Every two days until the end of the experiment | Xanthohumol significantly inhibited the growth of HT29 and HCT116 xenograft tumors, reducing tumor volume and weight | Int J Biol Sci. 2019 Sep 7;15(11):2497-2508. |
| Nude mice | HCC827OR and H1975OR xenograft model | Intraperitoneal injection | 10 mg/kg/2 days,30 mg/kg/2 days | Every 2 days, until tumor volume reached about 1000 mm3 | Xanthohumol significantly inhibited the tumor growth of HCC827OR and H1975OR cells in nude mice with no significant toxicity. | Cell Death Discov. 2024 Oct 28;10(1):454. |
| C57BL/6 mice | LPS-induced acute lung injury model | Intraperitoneal injection | 10 or 50 mg/kg | Single dose, 12 hours | To evaluate the protective effects of Xn on LPS-induced acute lung injury, the results showed that Xn significantly alleviated lung injury, reduced inflammatory cell infiltration and oxidative stress. | Redox Biol. 2017 Aug;12:311-324. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT02848430 | Food-Drug Interactions | Not Applicable | Active, not recruiting | October 18, 2018 | United States, Illinois ... 展开 >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 收起 << |
| NCT01982734 | Pharmacokinetics of New Curcum... 展开 >>in Formulations Safety of New Curcumin Formulations 收起 << | Early Phase 1 | Completed | - | Germany ... 展开 >> University of Hohenheim Stuttgart, Baden-Württemberg, Germany, 70599 收起 << |
| NCT03561116 | Metabolic Syndrome | Not Applicable | Recruiting | October 2018 | Portugal ... 展开 >> Medical Faculty of University of Porto Recruiting Porto, Portugal, 4200-319 Contact: Raquel Soares, PhD (+351)225513624 raqsoa@med.up.pt 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.82mL 0.56mL 0.28mL |
14.11mL 2.82mL 1.41mL |
28.22mL 5.64mL 2.82mL |
|
| CAS号 | 6754-58-1 |
| 分子式 | C21H22O5 |
| 分子量 | 354.4 |
| SMILES Code | O=C(C1=C(OC)C=C(O)C(C/C=C(C)\C)=C1O)/C=C/C2=CC=C(O)C=C2 |
| MDL No. | MFCD00210576 |
| 别名 | |
| 运输 | 蓝冰 |
| InChI Key | ORXQGKIUCDPEAJ-YRNVUSSQSA-N |
| Pubchem ID | 639665 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 85 mg/mL(239.84 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1